Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Total Current Liabilities (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Total Current Liabilities for 6 consecutive years, with $1.6 million as the latest value for Q3 2021.

  • Quarterly Total Current Liabilities rose 12.74% to $1.6 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Sep 2021, up 12.74% year-over-year, with the annual reading at $986663.0 for FY2020, 52.4% down from the prior year.
  • Total Current Liabilities for Q3 2021 was $1.6 million at ENDRA Life Sciences, down from $1.6 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $2.1 million in Q4 2019, with the low at $162302.0 in Q2 2017.
  • Average Total Current Liabilities over 5 years is $1.2 million, with a median of $1.3 million recorded in 2020.
  • The sharpest move saw Total Current Liabilities skyrocketed 112.68% in 2019, then plummeted 52.4% in 2020.
  • Over 5 years, Total Current Liabilities stood at $848214.0 in 2017, then grew by 14.9% to $974583.0 in 2018, then soared by 112.68% to $2.1 million in 2019, then tumbled by 52.4% to $986663.0 in 2020, then skyrocketed by 59.81% to $1.6 million in 2021.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $1.6 million, $1.6 million, and $765825.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.